The bulk of cases in India were the Delta variant and its related sub-variants
Key takeaways
According to the latest update from the World Health Organisation (WHO), Delta has outcompeted other variants in most countries and there was now “declining prevalence” of other variants among SARS-CoV-2 sequences
Public Health England stated that AY4.2, a Delta variant sublineage, was responsible for a “slowly increasing” proportion of cases in the U.K.
It is also present in multiple other countries and is seen in travellers to the U.K. from a large number of countries.
What is Indian SARS-CoV-2 Genomic Consortia (INSACOG)?
Coordinated by: Department of Biotechnology (DBT) along with MoH&FW, ICMR, and CSIR
The consortium will ascertain the status of a new variant of SARS-CoV-2 in the country.
INSACOG will have a high level Inter-Ministerial Steering Committee.
It will have a Scientific Advisory Group for scientific and technical guidance.
Aim: To monitor the genomic variations in the SARS-CoV-2 on a regular basis through a multi-laboratory network.
This vital research consortium will also assist in developing potential vaccines in the future.
The consortium will also establish a sentinel surveillance for early detection of genomic variants with public health implication, and determine the genomic variants in the unusual events/trends (super-spreader events, high mortality/morbidity trend areas etc.)
Do you know?
AY.x refers to a family of sublineages that can range from 1-25.
They have a common set of core mutations but large variation in others.
